M Morris

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi request reprint Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
    M Morris
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    N Engl J Med 340:1137-43. 1999
  2. ncbi request reprint Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
    M Morris
    Department of Gynecologic Oncology, University of Texas, M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 16:1094-8. 1998
  3. ncbi request reprint Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design
    K R Brader
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    J Clin Oncol 16:1879-84. 1998
  4. ncbi request reprint Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC)
    K M Sweeten
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Gynecol Oncol 59:211-5. 1995
  5. ncbi request reprint Posttherapy surveillance of women with cervical cancer: an outcomes analysis
    D Bodurka-Bevers
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Gynecol Oncol 78:187-93. 2000

Detail Information

Publications5

  1. ncbi request reprint Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
    M Morris
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    N Engl J Med 340:1137-43. 1999
    ..Patients were then to receive one or two applications of low-dose-rate intracavitary radiation, with a third cycle of chemotherapy planned for the second intracavitary procedure in the combined-therapy group...
  2. ncbi request reprint Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix
    M Morris
    Department of Gynecologic Oncology, University of Texas, M D Anderson Cancer Center, Houston 77030, USA
    J Clin Oncol 16:1094-8. 1998
    ..To evaluate the efficacy and toxicity of intravenous vinorelbine as single-agent chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the cervix...
  3. ncbi request reprint Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design
    K R Brader
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, USA
    J Clin Oncol 16:1879-84. 1998
    ..To identify characteristics that predict response to chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the cervix...
  4. ncbi request reprint Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC)
    K M Sweeten
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Gynecol Oncol 59:211-5. 1995
    ..The purpose of this study was to determine the responsiveness of refractory ovarian TCC to salvage chemotherapy...
  5. ncbi request reprint Posttherapy surveillance of women with cervical cancer: an outcomes analysis
    D Bodurka-Bevers
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Gynecol Oncol 78:187-93. 2000
    ..The aim of this study was to develop a surveillance program that optimizes clinical outcome following primary treatment of women with cervical cancer...